Items tagged with Advocacy

TAG policy brief: Advancing Access through Market Interventions (post with simple image)

Lessons Learned from the GeneXpert Tuberculosis Test Buy-Down

Public investment in bedaquiline up to five-fold that of Johnson & Johnson (post with simple image)

PLOS ONE publishes TAG’s rigorous, peer-reviewed calculation of investments in the development of this life-saving TB medicine.

Policy brief: COVID-19 – the new reality of Ending Tuberculosis (post with simple image)

A document, released by the TB Europe Coalition, in commemoration of the second anniversary of the signing of the UN Political Declaration on TB.

(post with simple image)

New survey finds millions of people affected by TB still diagnosed and treated with outdated tools (post with simple image)

Data on 37 countries reveals widespread failure to follow latest international recommendations for policies on prevention, diagnosis, and treatment.

Paediatric HIV & TB: Rome Action Plan (post with simple image)

EGPAF, WHO, PEPFAR, UNAIDS, Stop TB Partnership and FBOs: World Children’s Day statement on advances in access to paediatric HIV and TB diagnosis and treatments

New TAG report: Funding for TB research in 2019 nears half of global target (post with simple image)

The report — Tuberculosis Research Funding Trends, 2005–2019 — presents new data on 2019 funding for TB research and development and analyzes trends in investment since 2005.

A Deadly Divide: TB Commitments vs. TB Realities (post with simple image)

A communities report on progress towards the UN Political Declaration on the Fight Against TB and a Call to Action to close the gaps in TB targets

‘Catastrophic moral failure’: Stop TB Partnership joins WHO Director-General’s warning on COVID-19 vaccines (post with simple image)

Lack of access to COVID-19 vaccines for people in the world’s poorest countries echoes the health inequity faced by people affected by TB.

TB REACH Wave 9 now open for proposals (post with simple image)

Wave 9 to address shortcomings in drug-resistant TB care - linkage to care, uptake of novel treatment regimens and treatment outcomes.